KW-6500

DRUG3 trials

Sponsors

Kyowa Kirin Co., Ltd.

Conditions

Parkinson's Disease

Phase 3

Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease

CompletedNCT00955318

Kyowa Kirin Co., Ltd.Parkinson's Disease

Start: 2009-07-31End: 2012-03-31Updated: 2017-03-15

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500

CompletedNCT01058291

Kyowa Kirin Co., Ltd.Parkinson's Disease

Start: 2010-01-31End: 2010-10-31Updated: 2017-03-03

Extended Long-Term Safety Study of KW-6500

CompletedNCT01063621

Kyowa Kirin Co., Ltd.Parkinson's Disease

Start: 2010-01-31End: 2012-03-31Updated: 2017-03-15